World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
86
Citations
39577
World Ranking
13888
National Ranking
198

Manel Sabaté publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where Manel Sabaté sits on this spectrum.

101–120 publications: 5 scientists 121–140 publications: 26 scientists 141–160 publications: 73 scientists 161–180 publications: 155 scientists 181–200 publications: 230 scientists 201–220 publications: 363 scientists 221–240 publications: 487 scientists 241–260 publications: 545 scientists 261–280 publications: 722 scientists 281–300 publications: 768 scientists 301–320 publications: 834 scientists 321–340 publications: 895 scientists 341–360 publications: 922 scientists 361–380 publications: 838 scientists 381–400 publications: 861 scientists 401–420 publications: 918 scientists 421–440 publications: 806 scientists 441–460 publications: 771 scientists 461–480 publications: 751 scientists 481–500 publications: 713 scientists 501–520 publications: 617 scientists 521–540 publications: 611 scientists 541–560 publications: 537 scientists 561–580 publications: 504 scientists 581–600 publications: 509 scientists 601–620 publications: 396 scientists 621–640 publications: 386 scientists 641–660 publications: 371 scientists 661–680 publications: 340 scientists 681–700 publications: 336 scientists 701–720 publications: 307 scientists 721–740 publications: 259 scientists 741–760 publications: 230 scientists 761–780 publications: 228 scientists 781–800 publications: 217 scientists 801–820 publications: 204 scientists 821–840 publications: 186 scientists 841–860 publications: 177 scientists 861–880 publications: 155 scientists 881–900 publications: 139 scientists 901–920 publications: 145 scientists 921–940 publications: 116 scientists 941–960 publications: 133 scientists 961–980 publications: 91 scientists 981–1,000 publications: 96 scientists 1,001–1,020 publications: 77 scientists 1,021–1,040 publications: 70 scientists 1,041–1,060 publications: 63 scientists 1,061–1,080 publications: 77 scientists 1,081–1,100 publications: 49 scientists 1,101–1,120 publications: 54 scientists 1,121–1,140 publications: 49 scientists 1,141–1,160 publications: 51 scientists 1,161–1,180 publications: 35 scientists 1,181–1,200 publications: 39 scientists 1,201–1,220 publications: 26 scientists 1,221–1,240 publications: 37 scientists 1,241–1,260 publications: 36 scientists 1,261–1,280 publications: 27 scientists 1,281–1,300 publications: 32 scientists 1,301–1,320 publications: 28 scientists 1,321–1,340 publications: 17 scientists 1,341–1,360 publications: 30 scientists 1,361–1,380 publications: 28 scientists 1,381–1,400 publications: 17 scientists 1,401–1,420 publications: 21 scientists 1,421–1,440 publications: 15 scientists 1,441–1,460 publications: 12 scientists 1,461–1,480 publications: 12 scientists 1,481–1,500 publications: 18 scientists 1,501–1,520 publications: 14 scientists 1,521–1,540 publications: 17 scientists 1,541–1,560 publications: 15 scientists 1,561–1,580 publications: 6 scientists 1,581–1,600 publications: 2 scientists 1,601–1,620 publications: 12 scientists 1,621–1,640 publications: 11 scientists 1,641–1,660 publications: 8 scientists 1,661–1,680 publications: 5 scientists 1,681–1,700 publications: 5 scientists 1,701–1,720 publications: 10 scientists 1,721–1,740 publications: 12 scientists 1,741–1,760 publications: 14 scientists 1,761–1,780 publications: 6 scientists 1,781–1,795 publications: 5 scientists 1,796+ publications: 100 scientists
101 publications 1,796+

This scientist: 772 publications — 86th percentile

86% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,796 publications or more.

Manel Sabaté D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where Manel Sabaté sits on this spectrum.

70–71 D-Index: 226 scientists 72–73 D-Index: 391 scientists 74–75 D-Index: 574 scientists 76–77 D-Index: 730 scientists 78–79 D-Index: 891 scientists 80–81 D-Index: 972 scientists 82–83 D-Index: 1,027 scientists 84–85 D-Index: 1,003 scientists 86–87 D-Index: 960 scientists 88–89 D-Index: 970 scientists 90–91 D-Index: 922 scientists 92–93 D-Index: 839 scientists 94–95 D-Index: 808 scientists 96–97 D-Index: 779 scientists 98–99 D-Index: 668 scientists 100–101 D-Index: 611 scientists 102–103 D-Index: 630 scientists 104–105 D-Index: 513 scientists 106–107 D-Index: 541 scientists 108–109 D-Index: 445 scientists 110–111 D-Index: 429 scientists 112–113 D-Index: 400 scientists 114–115 D-Index: 393 scientists 116–117 D-Index: 318 scientists 118–119 D-Index: 302 scientists 120–121 D-Index: 287 scientists 122–123 D-Index: 255 scientists 124–125 D-Index: 256 scientists 126–127 D-Index: 252 scientists 128–129 D-Index: 230 scientists 130–131 D-Index: 179 scientists 132–133 D-Index: 168 scientists 134–135 D-Index: 163 scientists 136–137 D-Index: 159 scientists 138–139 D-Index: 134 scientists 140–141 D-Index: 134 scientists 142–143 D-Index: 118 scientists 144–145 D-Index: 109 scientists 146–147 D-Index: 106 scientists 148–149 D-Index: 74 scientists 150–151 D-Index: 79 scientists 152–153 D-Index: 80 scientists 154–155 D-Index: 87 scientists 156–157 D-Index: 57 scientists 158–159 D-Index: 74 scientists 160–161 D-Index: 69 scientists 162–163 D-Index: 60 scientists 164–165 D-Index: 53 scientists 166–167 D-Index: 39 scientists 168–169 D-Index: 42 scientists 170–171 D-Index: 32 scientists 172–173 D-Index: 39 scientists 174–175 D-Index: 40 scientists 176–177 D-Index: 28 scientists 178–179 D-Index: 19 scientists 180–181 D-Index: 23 scientists 182–183 D-Index: 31 scientists 184–185 D-Index: 18 scientists 186–187 D-Index: 20 scientists 188–189 D-Index: 22 scientists 190–191 D-Index: 13 scientists 192–193 D-Index: 21 scientists 194–195 D-Index: 12 scientists 196–197 D-Index: 12 scientists 198–199 D-Index: 14 scientists 200–201 D-Index: 15 scientists 202–203 D-Index: 13 scientists 204–205 D-Index: 10 scientists 206–207 D-Index: 8 scientists 208–209 D-Index: 4 scientists 210–211 D-Index: 12 scientists 212–213 D-Index: 11 scientists 214–215 D-Index: 10 scientists 216 D-Index: 4 scientists 217+ D-Index: 98 scientists
70 D-Index 217+

This scientist: 86 D-Index — 31st percentile

31% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 217 D-Index or more.

Overview

Manel Sabaté is affiliated with the University of Barcelona in Spain and has a primary research focus in Medicine, with a significant concentration in Cardiology and Cardiovascular Medicine. Their scholarly output includes extensive work in surgery, radiology, nuclear medicine and imaging, pulmonary and respiratory medicine, and epidemiology.

The scientist's research topics cover various aspects of cardiovascular medicine and related diagnostic and therapeutic areas. These include:

  • Coronary Interventions and Diagnostics
  • Cardiac Imaging and Diagnostics
  • Acute Myocardial Infarction Research
  • Cardiac Valve Diseases and Treatments
  • Antiplatelet Therapy and Cardiovascular Diseases
  • Cardiac Structural Anomalies and Repair
  • Infective Endocarditis Diagnosis and Management

Manel Sabaté has contributed to prominent journals and has a publication record concentrated in several key venues:

  • Journal of the American College of Cardiology
  • JACC: Cardiovascular Interventions
  • EuroIntervention
  • European Heart Journal
  • Cardiovascular Revascularization Medicine

Selected recent papers include:

  • "Venoarterial extracorporeal membrane oxygenation in patients with infarct-related cardiogenic shock: an individual patient data meta-analysis of randomised trials," 2023, The Lancet
  • "Immediate versus staged complete revascularisation in patients presenting with acute coronary syndrome and multivessel coronary disease (BIOVASC): a prospective, open-label, non-inferiority, randomised trial," 2023, The Lancet
  • "Venoarterial extracorporeal membrane oxygenation or standard care in patients with cardiogenic shock complicating acute myocardial infarction: the multicentre, randomised EURO SHOCK trial," 2023, EuroIntervention
  • "Implications of Alternative Definitions of Peri-Procedural Myocardial Infarction After Coronary Revascularization," 2020, Journal of the American College of Cardiology
  • "International Prospective Registry of Acute Coronary Syndromes in Patients With COVID-19," 2021, Journal of the American College of Cardiology

Frequent collaborators in their research endeavors include:

  • Salvatore Brugaletta
  • Ander Regueiro
  • Xavier Freixa
  • Luis Ortega-Paz
  • Fernándo Alfonso

Best Publications

  • 2013 ESC guidelines on the management of stable coronary artery disease: the Task Force on the management of stable coronary artery disease of the European Society of Cardiology.

    Gilles Montalescot;Udo Sechtem;Stephan Achenbach;Felicita Andreotti

  • Outcomes associated with drug-eluting and bare-metal stents: a collaborative network meta-analysis

    Christoph Stettler;Christoph Stettler;Simon Wandel;Sabin Allemann;Adnan Kastrati

  • Analysis of 14 trials comparing sirolimus-eluting stents with bare-metal stents.

    Adnan Kastrati;Julinda Mehilli;Jürgen Pache;Christoph Kaiser

  • Everolimus-Eluting Stents or Bypass Surgery for Left Main Coronary Artery Disease

    Gregg W. Stone;Joseph F. Sabik;Patrick W. Serruys;Charles A. Simonton

  • Stent thrombosis with drug-eluting and bare-metal stents: evidence from a comprehensive network meta-analysis

    Tullio Palmerini;Giuseppe Biondi-Zoccai;Diego Della Riva;Christoph Stettler

  • Drug-eluting stent thrombosis: results from a pooled analysis including 10 randomized studies.

    Raúl Moreno;Cristina Fernández;Rosana Hernández;Fernando Alfonso

  • Ticagrelor plus aspirin for 1 month, followed by ticagrelor monotherapy for 23 months vs aspirin plus clopidogrel or ticagrelor for 12 months, followed by aspirin monotherapy for 12 months after implantation of a drug-eluting stent: a multicentre, open-label, randomised superiority trial

    Pascal Vranckx;Marco Valgimigli;Peter Jüni;Christian Hamm

  • Platelet Function Profiles in Patients With Type 2 Diabetes and Coronary Artery Disease on Combined Aspirin and Clopidogrel Treatment

    Dominick J. Angiolillo;Antonio Fernandez-Ortiz;Esther Bernardo;Celia Ramírez

  • Five-Year Outcomes after PCI or CABG for Left Main Coronary Disease

    Gregg W. Stone;A. Pieter Kappetein;Joseph F. Sabik;Stuart J. Pocock

  • Comparison of an everolimus-eluting bioresorbable scaffold with an everolimus-eluting metallic stent for the treatment of coronary artery stenosis (ABSORB II): a 3 year, randomised, controlled, single-blind, multicentre clinical trial

    Patrick W Serruys;Bernard Chevalier;Yohei Sotomi;Angel Cequier

  • Percutaneous coronary intervention versus coronary artery bypass grafting in patients with three-vessel or left main coronary artery disease: 10-year follow-up of the multicentre randomised controlled SYNTAX trial.

    Daniel J F M Thuijs;A Pieter Kappetein;Patrick W Serruys;Friedrich-Wilhelm Mohr

  • Late Coronary Occlusion After Intracoronary Brachytherapy

    Marco A. Costa;Manel Sabaté;Wim J. van der Giessen;I. Patrick Kay

  • Randomized Comparison of Sirolimus-Eluting Stent Versus Standard Stent for Percutaneous Coronary Revascularization in Diabetic Patients The Diabetes and Sirolimus-Eluting Stent (DIABETES) Trial

    Manel Sabaté;Pilar Jiménez-Quevedo;Dominick J. Angiolillo;Joan Antoni Gómez-Hospital

  • Everolimus-eluting stent versus bare-metal stent in ST-segment elevation myocardial infarction (EXAMINATION): 1 year results of a randomised controlled trial

    Manel Sabate;Angel Cequier;Andrés Iñiguez;Antonio Serra

  • Consensus document on the radial approach in percutaneous cardiovascular interventions: position paper by the European Association of Percutaneous Cardiovascular Interventions and Working Groups on Acute Cardiac Care** and Thrombosis of the European Society of Cardiology.

    Martial Hamon;Christian Pristipino;Carlo Di Mario;James Nolan

  • Reperfusion therapy for ST elevation acute myocardial infarction 2010/2011: current status in 37 ESC countries.

    Steen D. Kristensen;Kristina G. Laut;Jean Fajadet;Zuzana Kaifoszova

  • Impact of Platelet Reactivity on Cardiovascular Outcomes in Patients With Type 2 Diabetes Mellitus and Coronary Artery Disease

    Dominick J. Angiolillo;Esther Bernardo;Manel Sabaté;Pilar Jimenez-Quevedo

  • High clopidogrel loading dose during coronary stenting: effects on drug response and interindividual variability

    Dominick J. Angiolillo;Antonio Fernández-Ortiz;Esther Bernardo;Celia Ramírez

  • Bivalirudin or Unfractionated Heparin in Acute Coronary Syndromes

    Marco Valgimigli;Enrico Frigoli;Sergio Leonardi;Martina Rothenbühler

  • Insulin Therapy Is Associated With Platelet Dysfunction in Patients With Type 2 Diabetes Mellitus on Dual Oral Antiplatelet Treatment

    Dominick J. Angiolillo;Esther Bernardo;Celia Ramírez;Marco A. Costa

Frequent Co-Authors

Patrick W. Serruys
Patrick W. Serruys University of Galway
Fernando Alfonso
Fernando Alfonso Hospital Universitario de La Princesa
Carlos Macaya
Carlos Macaya Complutense University of Madrid
Javier Escaned
Javier Escaned Hospital Clínico San Carlos
Dominick J. Angiolillo
Dominick J. Angiolillo University of Florida
Stephan Windecker
Stephan Windecker University of Bern
Marco Valgimigli
Marco Valgimigli University of Bern
Carlo Di Mario
Carlo Di Mario University of Florence
Yoshinobu Onuma
Yoshinobu Onuma University of Galway
Adrian P. Banning
Adrian P. Banning University of Oxford

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring a career in Medicine opens doors to a range of online degree options that support advancement in healthcare fields. For those seeking leadership or administrative roles, pursuing an online master of health administration delivers the flexibility and credentials needed to succeed. Online programs make it easier for busy professionals to continue their education without compromising their work commitments.

Affordability is an important concern for many students. Investigating cheap mha programs helps future leaders find pathways that minimize student debt while maximizing career value. These programs typically provide the same academic rigor as their on-campus counterparts.

For nurses aiming to reach the highest level of practice, msn to dnp programs online allow them to progress from a Master of Science in Nursing to a Doctor of Nursing Practice. This shift can help expand clinical expertise and leadership capabilities.

Pharmacy professionals can also advance their credentials through online pharmacy school programs. These programs provide access to top-tier education and greater career mobility, all while offering the convenience of distance learning.

Best Scientists Citing Manel Sabaté

Trending Scientists

Recently Published Articles